Aayush Wellness to form subsidiary in Singapore to drive Southeast Asia expansion
This strategic expansion marks a significant step in the company's global growth strategy
This strategic expansion marks a significant step in the company's global growth strategy
Newly commissioned MCC in Jhagadia and Dahej and CCS project expansions will unlock an additional 8,800 MTPA, fuelling year-over-year revenue gains of 20%-30% in excipients
Operating income on consolidated basis increased by 38.10% at Rs 44.58 crore in Q4 FY25
This strategic move positions Sudeep Pharma to seamlessly integrate high-end premix capabilities with its mineral portfolio
Record international participation reflects renewed momentum in pharma manufacturing and global sourcing, as easing tariffs fuel growth
This global affiliation marks a critical step in the company’s mission to create long-term value through ethical practices, scientific innovation, and inclusive healthcare delivery
In Q4 FY25, our pharmaceutical business reported revenue growth of 20% to Rs 351 crore and EBIT growth of 65% to Rs 55 croe, on QoQ basis
This marks yet another milestone in our series of successful audits over the past year
Subscribe To Our Newsletter & Stay Updated